Glaukos director exercises 15,000 stock options

GLAUKOS Corp director David F. Hoffmeister exercised stock options to acquire 15,000 shares of Common Stock at $24.69 per share.

Rhea-AI Filing Summary

GLAUKOS Corp director David F. Hoffmeister exercised stock options to acquire 15,000 shares of Common Stock at $24.69 per share. The exercised options were granted on June 2, 2016 and were fully vested by the first anniversary of the grant date, and now show zero remaining. After the transaction, he holds 47,671 shares of Common Stock directly, which include 2,861 restricted stock units that are unvested or deferred, and 38,176 shares indirectly through Sentinel Point Partners, Inc.

Insider Trade Summary

15,000 shares exercised/converted

Exercise 3 txns

Insider Hoffmeister David F

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	15,000	$24.69	$370K
Exercise	Common Stock	15,000	$24.69	$370K
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 47,671 shares (Direct); Common Stock — 38,176 shares (Indirect, Through Sentinel Point Partners, Inc.)

Footnotes (2)

1. F1. Includes 2,861 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person.
2. F2. This option was granted on June 2, 2016 and fully vested on the first anniversary of the grant date.

Key Figures

Options exercised: 15,000 shares Exercise price: $24.69 per share Direct common shares after exercise: 47,671 shares +5 more

8 metrics

Options exercised 15,000 shares Stock Option (Right to Buy) exercised into Common Stock

Exercise price $24.69 per share Exercise or conversion of derivative security

Direct common shares after exercise 47,671 shares Total direct Common Stock holdings following transaction

Indirect common shares 38,176 shares Held through Sentinel Point Partners, Inc.

Restricted stock units included 2,861 RSUs Unvested or delivery-deferred RSUs within direct holdings

Remaining options after exercise 0 options Stock Option (Right to Buy) total shares following transaction

Option grant date June 2, 2016 Grant date for exercised stock option

Option expiration date June 2, 2026 Expiration date of exercised stock option

Key Terms

Stock Option (Right to Buy), derivative security, restricted stock units, indirect ownership, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

derivative security financial

"transaction_code_description: "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

restricted stock units financial

"Includes 2,861 restricted stock units that have not vested or been delivered"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

indirect ownership financial

"ownership_type: "indirect" and nature_of_ownership: "Through Sentinel Point Partners, Inc.""

fully vested financial

"This option was granted on June 2, 2016 and fully vested on the first anniversary"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Glaukos (GKOS) director David F. Hoffmeister report in this Form 4?

David F. Hoffmeister reported exercising stock options for 15,000 Glaukos common shares at $24.69 per share. These options were originally granted in June 2016 and were fully vested, converting his derivative position into additional directly held common stock.

How many Glaukos (GKOS) shares does David F. Hoffmeister hold after the reported transactions?

After the reported activity, David F. Hoffmeister holds 47,671 Glaukos common shares directly and 38,176 shares indirectly through Sentinel Point Partners, Inc. The direct holdings include 2,861 restricted stock units that are either unvested or vested with delivery deferred.

What was the exercise price of David F. Hoffmeister’s Glaukos (GKOS) stock options?

The exercised Glaukos stock options had an exercise price of $24.69 per share for 15,000 underlying common shares. These options were granted on June 2, 2016 and had fully vested by the first anniversary of the grant date before being exercised.

Did David F. Hoffmeister sell any Glaukos (GKOS) shares in this Form 4 filing?

The filing shows an exercise of stock options for 15,000 Glaukos shares but no reported sales. One line reflects a holding entry for 38,176 shares held indirectly through Sentinel Point Partners, Inc., indicating ownership structure rather than an open-market disposition.

What does the Form 4 say about David F. Hoffmeister’s Glaukos (GKOS) restricted stock units?

The Form 4 notes that his direct holdings include 2,861 restricted stock units. These units have not yet vested or been delivered, or have vested with delivery deferred, meaning they represent additional potential equity not yet settled as freely tradable shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/28/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoffmeister David F

(Last) (First) (Middle)

C/O GLAUKOS CORPORATION

ONE GLAUKOS WAY

(Street)

ALISO VIEJO CALIFORNIA 92656

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GLAUKOS Corp [ GKOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/26/2026		M		15,000	A	$24.69	47,671(1)	D
Common Stock								38,176	I	Through Sentinel Point Partners, Inc.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$24.69	05/26/2026		M			15,000	06/02/2017(2)	06/02/2026	Common Stock	15,000	$24.69	0	D

Explanation of Responses:

1. Includes 2,861 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person.

2. This option was granted on June 2, 2016 and fully vested on the first anniversary of the grant date.

	Diana Scherer, Attorney-in-Fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)